Difficulty: Medium
Average Score: 84%
Practice
In the treatment of congenital adrenal hyperplasia in which there is excess production of cortisol precursor, the purpose of administration of synthetic glucocorticoid is:
Correct answer
D
Rationale
In the treatment of congenital adrenal hyperplasia (CAH), which involves excess production of cortisol precursor due to enzymatic deficiencies, the administration of synthetic glucocorticoids serves the purpose of suppressing ACTH secretion. ACTH (adrenocorticotropic hormone) is responsible for stimulating the adrenal glands to produce cortisol. By providing exogenous glucocorticoids, the negative feedback mechanism is triggered, leading to a decrease in ACTH production from the pituitary gland. This, in turn, reduces the stimulation of the adrenal glands, thereby decreasing the production of excessive cortisol precursors.
Option A, inhibition of aldosterone secretion, is incorrect because glucocorticoids primarily affect cortisol production, not aldosterone, which is regulated by the renin-angiotensin-aldosterone system.
Option B, normalization of renal function, is incorrect as the primary goal of glucocorticoid administration in CAH is to address the hormonal imbalance, not specifically to target renal function.
Option C, recovery of normal immune function, is incorrect because while glucocorticoids have immunosuppressive effects, in the context of CAH treatment, the primary aim is to regulate cortisol levels and not specifically to address immune function.
Understanding the rationale behind the choice of the correct answer is vital for nursing students preparing for the NCLEX exam. It demonstrates the importance of recognizing the pathophysiology of CAH and the mechanism of action of glucocorticoid therapy in managing this condition. By grasping this concept, nurses can provide effective care to patients with CAH and other endocrine disorders, ensuring optimal outcomes.
Option A, inhibition of aldosterone secretion, is incorrect because glucocorticoids primarily affect cortisol production, not aldosterone, which is regulated by the renin-angiotensin-aldosterone system.
Option B, normalization of renal function, is incorrect as the primary goal of glucocorticoid administration in CAH is to address the hormonal imbalance, not specifically to target renal function.
Option C, recovery of normal immune function, is incorrect because while glucocorticoids have immunosuppressive effects, in the context of CAH treatment, the primary aim is to regulate cortisol levels and not specifically to address immune function.
Understanding the rationale behind the choice of the correct answer is vital for nursing students preparing for the NCLEX exam. It demonstrates the importance of recognizing the pathophysiology of CAH and the mechanism of action of glucocorticoid therapy in managing this condition. By grasping this concept, nurses can provide effective care to patients with CAH and other endocrine disorders, ensuring optimal outcomes.